Nano-Formulations of Natural Antioxidants for the Treatment of Liver Cancer

Author:

Cristani Mariateresa1ORCID,Citarella Andrea2ORCID,Carnamucio Federica3,Micale Nicola1ORCID

Affiliation:

1. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D’Alcontres 31, I-98166 Messina, Italy

2. Department of Chemistry, University of Milan, Via Golgi 19, I-20133 Milano, Italy

3. Center of Pharmaceutical Engineering and Sciences, Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA 23284, USA

Abstract

Oxidative stress is a key factor in the pathological processes that trigger various chronic liver diseases, and significantly contributes to the development of hepatocarcinogenesis. Natural antioxidants reduce oxidative stress by neutralizing free radicals and play a crucial role in the treatment of free-radical-induced liver diseases. However, their efficacy is often limited by poor bioavailability and metabolic stability. To address these limitations, recent advances have focused on developing nano-drug delivery systems that protect them from degradation and enhance their therapeutic potential. Among the several critical benefits, they showed to be able to improve bioavailability and targeted delivery, thereby reducing off-target effects by specifically directing the antioxidant to the liver tumor site. Moreover, these nanosystems led to sustained release, prolonging the therapeutic effect over time. Some of them also exhibited synergistic effects when combined with other therapeutic agents, allowing for improved overall efficacy. This review aims to discuss recent scientific advances in nano-formulations containing natural antioxidant molecules, highlighting their potential as promising therapeutic approaches for the treatment of liver cancer. The novelty of this review lies in its comprehensive focus on the latest developments in nano-formulations of natural antioxidants for the treatment of liver cancer.

Publisher

MDPI AG

Reference183 articles.

1. The latest global burden of liver cancer: A past and present threat;Oh;Clin. Mol. Hepatol.,2023

2. (2024, July 29). Liver Cancer Statistics | World Cancer Research Fund International. WCRF International. Available online: https://www.wcrf.org/cancer-trends/liver-cancer-statistics/.

3. Jiang, K., Al-Diffalha, S., and Centeno, B.A. (2018). Primary Liver Cancers—Part 1. Cancer Control., 25.

4. Jiang, K., and Centeno, B.A. (2018). Primary Liver Cancers, Part 2. Cancer Control., 25.

5. Liver metastases;Tsilimigras;Nat. Rev. Dis. Prim.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3